Home
>
National Drug Code (NDC)
>
NAPROXEN
NAPROXEN - 10544-111-20 - (NAPROXEN)
Drug Information of NAPROXEN
| Product NDC: | 10544-111 |
| Proprietary Name: | NAPROXEN |
| Non Proprietary Name: | NAPROXEN |
| Active Ingredient(s): | 500 mg/1 & nbsp; NAPROXEN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NAPROXEN
| Product NDC: | 10544-111 |
| Labeler Name: | Blenheim Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091416 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130328 |
Package Information of NAPROXEN
| Package NDC: | 10544-111-20 |
| Package Description: | 20 TABLET in 1 BOTTLE (10544-111-20) |
NDC Information of NAPROXEN
| NDC Code | 10544-111-20 |
| Proprietary Name | NAPROXEN |
| Package Description | 20 TABLET in 1 BOTTLE (10544-111-20) |
| Product NDC | 10544-111 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NAPROXEN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130328 |
| Marketing Category Name | ANDA |
| Labeler Name | Blenheim Pharmacal, Inc. |
| Substance Name | NAPROXEN |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
